Leukotriene Antagonist

Leukotriene Antagonist


LEUKOTRIENE ANTAGONIST

  • Are also referred as “Leukotriene Receptor Antagonists” (LTRA’s).
  • Non-steroidal anti-inflammatory bronchoconstriction preventors. 
  • Work by blocking inflammatory reactions in airways.
MECHANISM OF ACTION:

Two main approaches to block leukotrienes actions:

Inhibition of 5-lipoxygenase pathway

  • Drugs inhibiting 5-lipoxygenase enzyme will inhibit synthetic pathway of leukotriene metabolism
  • MK-886 – Blocks 5-lipoxygenase activating protein (FLAP), inhibiting 5-lipoxygenase enzyme functioning & helps in treating atherosclerosis.

Antagonism of cysteinyl-leukotriene type 1 receptors

  • Eg: Montelukast & Zafirlukast.
  • Blocks cysteinyl leukotriene actions at CysLT1 receptor on bronchial smooth muscle via receptor antagonism.
  • Helps improve asthma symptoms, reduce asthma exacerbation, limit inflammation markers such as eosinophil counts in peripheral blood & bronchoalveolar lavage fluid. 
  • Hence, are anti-inflammatory.

MONTELUKAST:

  • A LTRA (Leukotriene receptor antagonist).
  • Usually administered orally.
  • More acceptable in children.

Mechanism of action:

CysLT1 antagonist:

  • Blocks leukotriene D4 action on cysteinyl leukotriene receptor CysLT1 in lungs & bronchial tubes by binding to it. 
  • Hence, reduces bronchoconstriction & results in less inflammation.

Indications:

  • Indicated for prophylactic therapy of mild to moderate asthma.
  • As an alternative to inhaled glucocorticoids.
  • Used in maintenance therapy of asthma & relief of seasonal allergies.

Contraindications:

  • Not used in terminating asthma episodes.
  • Not useful in treating acute asthma attacks. 
  • Due to its very specific action, it does not interact with other allergy medications like theophylline.

SIDE EFFECTS:

  • Gastrointestinal disturbances
  • Hypersensitivity reactions
  • Sleep disorders 
  • Increased bleeding tendency
  • Higher incidence of Churg-Strauss syndrome
Exam Question
 
  • Montelukast mechanism of action is Competitive inhibition of leukotriene synthesis
  • Montelukast is leukotriene antagonist
  • The leukotriene receptor antagonist used in bronchial asthma is Zafirlukast
  • Leukotrienes antagonists are effective in aspirin-induced asthma.
Don’t Forget to Solve all the previous Year Question asked on Leukotriene Antagonist

Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support